Company · CIK 0001860742 · SIC 3851 — Ophthalmic Goods · NYSE
Bausch & Lomb Corp · BLCO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 AForm 4 → | Aug 14, 5:47 pm EDT | Barbara TrebbiDirector | 11,776 | — | — | 11,776 | — | |
| Aug 12, 2026 AForm 4 → | Aug 14, 5:34 pm EDT | Laurence E PaulDirector | 11,776 | — | — | 11,776 | — | |
| Aug 12, 2026 AForm 4 → | Aug 14, 5:25 pm EDT | Robert J ChersiDirector | 11,776 | — | — | 11,776 | — | |
| Aug 10, 2026 SForm 4 → | Aug 12, 7:06 pm EDT | Frederick MunschSVP, Controller and CAO | 52,900 | $16.78 | $887,662 | 45,831 | −53.6% | |
| Aug 6, 2026 SForm 4 → | Aug 10, 8:57 pm EDT | Andrew C. Von EschenbachDirector | 18,559 | $16.53 | $306,708 | 63,733 | −22.6% | |
| Aug 5, 2026 AForm 4 → | Aug 7, 4:54 pm EDT | Andrew J. StewartPresident, GPIC | 16,778 | — | — | 103,211 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 4:53 pm EDT | Frederick MunschSVP, Controller and CAO | 9,091 | — | — | 98,731 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 4:50 pm EDT | Yehia HashadEVP of R&D and CMO | 20,973 | — | — | 187,350 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 4:42 pm EDT | Sam EldessoukyEVP and CFO | 50,335 | — | — | 393,527 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 4:35 pm EDT | Luc BonnefoyPresident, Surgical | 16,778 | — | — | 103,801 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 4:32 pm EDT | A Robert D BaileyEVP & Chief Legal Officer | 33,557 | — | — | 264,241 | — | |
| Aug 5, 2026 AFForm 4 → | Aug 7, 4:30 pm EDT | Brent L SaundersChairman of the Board and CEO, Director | 286,110 | $16.76 | $70,912 | 1,256,037 | — | |
| Jun 12, 2026 FForm 4 → | Jun 16, 4:16 pm EDT | Luc BonnefoyPresident, Surgical | 1,008 | $15.08 | $15,201 | 87,023 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.